Kelyniam Global, Inc.
$0.10$0.00 (0.0%)
Kelyniam Global, Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
OTC · MSIU · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Medical Supply International USA, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.12% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Medical Supply International USA, Inc. (MSIU), through its subsidiaries, delivers a spectrum of rehabilitation and specialized hospital services within the healthcare industry of the People's Republic of China. The company operates a dedicated rehabilitative center and a hospital focused on maternity and other specialized medical services. The rehabilitative facility provides therapeutic and medical interventions for patients recuperating from severe injuries, illnesses, or addiction. Additionally, MSIU manages an outpatient clinic offering services like private consultations, health screening programs, and obstetrics and gynecology care. The firm also leverages advanced technologies such as 4-D ultrasound for diagnostic imaging, employs IPL systems for treating various skin conditions, and performs cosmetic surgical procedures. Founded in 2001, the company was originally known as Master Spirit International USA Inc. before rebranding to Medical Supply International USA, Inc. in October 2018. Its corporate headquarters are situated in Wan Chai, Hong Kong.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:48 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.10$0.00 (0.0%)
Kelyniam Global, Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
$0.31+$0.01 (+3.33%)
QHSLab, Inc.’s quoted price sits in the lower half of its reported 52-week range, 72.81% below the high.
$0.03$0.00 (0.0%)
CordovaCann Corp.’s quoted price sits in the lower half of its reported 52-week range, 57.14% below the high.
$0.25$0.00 (0.0%)
Strainsforpains, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.02$0.00 (0.0%)
United American Healthcare Corporation’s quoted price sits in the lower half of its reported 52-week range, 30.77% below the high.
$0.00-$0.00 (-14.29%)
SOHM, Inc.’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
$0.01-$0.01 (-50.0%)
Yubo International Biotech Limited’s quoted price sits in the lower half of its reported 52-week range, 64.24% below the high.
$0.00$0.00 (0.0%)
Pressure BioSciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.75% below the high.